Identification of structural variations in the carboxyl terminus of Alzheimer's disease-associated βA4[1-42] amyloid using a monoclonal antibody

Clinical and Experimental Immunology

Volumn 124, Issue 2, 2001, Pages 297-305

  Jayasena, U L H R ^a   Gribble, S K ^a   Mckenzie, A ^a   Beyreuther, K ^c   Masters, C L ^a,b   Underwood, J R ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

A4; Alzheimer's disease; Amyloid; Monoclonal antibody; Polypeptide

Indexed keywords

AMINO ACID; AMYLOID; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN BETA A4; UNCLASSIFIED DRUG;

ADSORPTION; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEAT SENSITIVITY; HYBRIDOMA; IODINATION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; VASCULAR DISEASE;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPE MAPPING; EPITOPES; HUMANS; HYBRIDOMAS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 0034951604     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01209.x     Document Type: Article

References (21)

1. Amyloid deposits and amyloidosis; the β-fibrilloses
2. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
3. βA4 amyloid protein and its precursor in Alzheimer's disease
4. Amyloid βA4 of Alzheimer's disease: Structural requirements for folding and aggregation
5. Evidence that Aβ42 is the real culprit in Alzheimer's disease
6. The COOH-terminus of the Alzheimer amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits
7. Structural determinants of Alzheimer's amyloid β-peptide
8. Solution conformations and aggregational properties synthetic amyloid β-peptides of Alzheimer's disease: Analysis of circular dichroism spectra
9. Hybrids from normal, germ free, nude and neonatal mice produce monoclonal autoantibodies to eight different intracellular structures
10. L domain sequences
11. -/Io/int thymocyte subpopulation exhibits extensive polyspecificity
12. Human brain βA4 amyloid protein precursor of Alzheimer's disease: Purification and partial characterization
13. Use of monoclonal antibodies to detect conformational alterations in lactate dehydrogenase isoenzyme 5 on heat denaturation and on adsorption to polystyrene plates
14. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic β-protein fragments
15. Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition
16. NMR studies of amyloid β-peptides: Proton assignments, secondary structure and mechanism of an α-helix (r) β-sheet conversion for a homologous, 28-residue, N-terminal fragment
17. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
18. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
19. Model of the β protein C-terminus: Differences in amyloid structure may lead to segregation of 'long' and 'short' fibrils
20. Peptide models of hydrophobic cluster at the C-terminus of the β-amyloid protein
21. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay